Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib.
about
Management of solitary and multiple brain metastases from breast cancerRelationship between HER-2 overexpression and brain metastasis in esophageal cancer patients.Systemic treatment after whole-brain radiotherapy may improve survival in RPA class II/III breast cancer patients with brain metastasis.Incidence and time trends of brain metastases admissions among breast cancer patients in SwedenA phase 1 study of a heterologous prime-boost vaccination involving a truncated HER2 sequence in patients with HER2-expressing breast cancer.Nearly Complete Response of Brain Metastases from HER2 Overexpressing Breast Cancer with Lapatinib and Capecitabine after Whole Brain Irradiation.Lapatinib and breast cancer: current indications and outlook for the future.Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: clinical and in vitro evidence.Predicting survival in women with breast cancer and brain metastasis: a nomogram outperforms current survival prediction models.Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases.Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the AnatolianT lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression.Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development.Prognostic factors of HER2-positive breast cancer patients who develop brain metastasis: a multicenter retrospective analysis.Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis.Astatine-211 labeled anti-HER2 5F7 single domain antibody fragment conjugates: radiolabeling and preliminary evaluation.Breast cancer subtype as a predictor for outcomes and control in the setting of brain metastases treated with stereotactic radiosurgery.
P2860
Q26865562-DA7D2B3A-126F-4713-9065-C29719BE44DBQ34285753-06B0D37C-1FD8-476D-8AE3-BDF6623FC569Q34762284-FEEA5A39-3EC3-47B9-99D7-5E29EDB0F3ACQ35998465-F661DF93-4A79-42B5-9C17-4FF21954616BQ36106412-ADDD6A45-8383-45F8-B696-B9261E8FA5E1Q37244367-13F1ECB9-7AD2-4ED0-8FB4-658CDAF970B9Q37782086-19A3E01B-473C-492C-B51C-EBF4DBFE02A6Q39389259-671879D2-A81E-4096-B2CB-DB67BF8029B3Q43927646-AFFA1883-CB64-4621-B1D1-9C5A7A00E4CCQ47141003-F72ACEE6-BED4-4ED2-A1F7-0F977DCD248BQ47793228-D6601747-5DB9-47C6-AF28-84ACD726A78CQ47852200-557544A2-A32D-42E8-9C35-F4787BD49BF7Q48213140-D7F4A21C-393C-4518-A245-635BA570E680Q48404872-42323102-68C7-42DD-8136-ABDC0D79FED5Q48614511-16967387-BE41-42D2-98FB-BF7502E54645Q50068024-B740CBEB-9780-47A6-8CE7-11DADE3D8097Q52145778-839A19BE-D37E-46E8-BAC4-F4705B826ECF
P2860
Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib.
@en
Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib.
@nl
type
label
Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib.
@en
Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib.
@nl
prefLabel
Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib.
@en
Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib.
@nl
P2093
P50
P1476
Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib.
@en
P2093
Daniel Devriendt
Dominique Lossignol
Gianluca Tomasello
P304
P356
10.1016/J.CRITREVONC.2009.11.003
P577
2009-12-09T00:00:00Z